INTERNATIONAL PATENT: ASTERO BIOPHARMA LLC FILES APPLICATION FOR "APPROACHES FOR THE SELECTIVE DEPLETION OF PLA2R-SPECIFIC ANTIBODIES"

GENEVA, Dec. 24 -- ASTERO BIOPHARMA LLC (8405 Spring CreekCollege Station, TX 77845) filed a patent application (PCT/US2025/033479) for "APPROACHES FOR THE SELECTIVE DEPLETION OF PLA2R-SPECIFIC ANTIBODIES" on Jun 13, 2025. With publication no. WO/2025/259945, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WARD OBER, Elizabeth Sally (8405 Spring CreekCollege Station, TX 77845)

Abstract: The present disclosure includes a fusion protein or molecule, called a "Macromolecule that depletes PLA2R-specific antibodies" including...